Hodgkin's disease: Controversies in the treatment of stages I and II;Linfoma di Hodgkin: Problematiche nel trattamento degli stadi iniziali

Radiologia Medica

Volumn 92, Issue 5, 1996, Pages 620-623

  Bacigalupo, Almalina ^a   Barra, Salvina ^a   Corvò, Renzo ^a   Guenzi, Marina ^a   Scolaro, Tindaro ^a   Vitale, Vito ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Hodgkin's disease, chemotherapy, radiotherapy; Hodgkin's disease, prognostic factors; Hodgkin's disease, stages I and II

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMBINATION CHEMOTHERAPY; HODGKIN DISEASE; HUMAN; IRRADIATION; MORBIDITY; PROGNOSIS; SHORT SURVEY;

HODGKIN DISEASE; HUMANS; NEOPLASM STAGING; PROGNOSIS;

EID: 0030468349     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (25)

1. Bartlett NL, Rosenberg SA, Hoppe RT e Coll: 12 Weeks of chemotherapy and involved field radiotherapy (RT) are highly effective for unfavorable Hodgkin's disease (HD): The Standford V regimen. Atti XXXV Annual Meeting, Am. Soc. Hematol., St. Louis, 1993.
2. Bates NP, Williams MV, Bessell EM e Coll: Efficacy and toxicity of Vinblastine, Bleomycin and Methotrexate with involved-field radiotherapy in clinical stage IA and IIA Hodgkin's disease: a British National Lymphoma Investigation pilot study J Clin Oncol 12, 288-296, 1994.
3. Bitt GP, Cellai E, Magrini S e Coll: Second solid tumors and leukemia after treatment for Hodgkin's disease an analysis of 1121 patients from a single institution Int J Radiat Oncol Biol Phys 29: 25-31, 1994.
4. Biti GP, Cimino C, Magrini SM e Coll: Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-II Hodgkin's disease: eight-year update of an Italian prospective randomized study. J Clin Oncol 10: 378-382, 1992.
5. Bonadonna G: Modern treatment of malignant lymphomas, a multidisciplinary approach? Ann Oncol 5 (suppl. 2): 5-16, 1994.
6. Bonfante V, Santoro A, Viviani S e Coll: ABVD plus radiotherapy (subtotal nodal vs involved field) in early-stage Hodgkin's disease (HD). Atti ASCO, 13: 373, 1994.
7. Carde P, Hagenbeek A, Hayat M e Coll Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's Disease: the H6 Twin Randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 11: 2258-2272, 1993
8. Farah R, Ultmann J, Griem M e Coll: Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol 6: 1047-1052, 1988.
9. Hoppe RT. Radiation therapy in the management of Hodgkin's disease. Semin Oncol 17: 704-715, 1990.
10. Hoppe RT: Hodgkin's disease strategy-stage I-II. In: Somers R, Henry-Amara M, Meerwaldt M e Coll (eds): Treatment strategy in Hodgkin disease. John Libbey Eurotext Ltd., INSERM Pans, 196, 1: 155-166, 1990.
11. Hoppe RT, Hanlon AL, Hanks GE e Coll: Progress in the treatment of Hodgkin's disease in the United States, 1973 versus 1983; the pattern of care study Cancer 74: 3198-3203, 1994.
12. Homing SJ, Hoppe RT, Hancock SL e Coll: Vinblastine, bleomycin and methotrexate: an effective adjuvant therapy in favorable Hodgkin's disease. J Clin Oncol 6: 1822-1831, 1988.
13. Klasa RJ, Connors J, Hoskins P e Coll: Early stage Hodgkin's disease impact of brief chemotherapy together with radiotherapy without staging laparotomy. Atti ASCO 13: 1994.
14. Lee CKK, Aeppli DM, Bloomfield DC e Coll: Curative radiotherapy for laparotomy-staged IA, IIA, IIIA Hodgkin's disease. An evaluation of the gains achieved with radical radiotherapy. Int J Radiat Oncol Biol Phys 19 547-559, 1990.
15. Longo DL, Glatstein E, Duffey PL e Coll: Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial. J Clin Oncol 9: 906-917, 1991.
16. Mauch MP, Cabellos GP, Shulman LN e Coll: Mantle irradiation alone for selected patients with laparotomy - staged IA to IIA Hodgkin's disease, preliminary results of a prospective trial. J Clin Oncol 13: 947-952, 1995.
17. Rosenberg SA: The treatment of Hodgkin's disease Ann Oncol 5: 17-21, 1994.
18. Rosenberg SA: Modern combined modality management of Hodgkin's disease. Curr Opinion Oncol 6: 470-472, 1994.
19. Sutcliffe S, Gospodarowicz M, Bergsagel D e Coll. Prognostic groups for management of localized Hodgkin's disease. J Clin Oncol 3: 393-401, 1985.
20. Timothy AR, Sutcliffe SB, Stansfeld AG e Coll. Radiotherapy in the treatment of Hodgkin's disease. Br Med 11: 1246-1249, 1978.
21. Tubiana M, Henry-Amar M, Carde P e Coll: Toward comprehensive management tailored to prognostic factors of patients with clinical stage I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987. Blood 73: 47-56, 1989.
22. Tubiana M, Henry-Amar M, Hayat M e Coll: The EORTC treatment of early stage of Hodgkin's disease: the role of radiotherapy. Int J Radiat Oncol Biol Phys 10: 197-210, 1984
23. Willet CG, Linggood RM, Meyer J e Coll: Results of treatment of stage IA and IIA Hodgkin's disease. Cancer 59: 1107-1111, 1987.
24. Zagars G, Rubin P: Hodgkin's disease stage IA and IIA, a long-term follow-up study on gains achieved by modern therapy. Cancer 56: 2905-2912, 1985.
25. Zanini M, Viviani S, Santoro A e Coll. Extended field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage). Int J Radiat Oncol Biol Phys 30: 813-819, 1994.